好模式离不开硬技术。为让林下种植走上标准化之路，村"两委"和驻村工作队组织种植户赴陕西宝鸡考察取经，邀请药材公司专家现场授课，从菌棒 培育到田间管理，全程为村民提供技术护航。 "以前种庄稼靠老经验，现在种药材有'科技范儿'，心里特别踏实。"脱贫户马克菊一边给猪苓培土一边说，如今在基地务工，一年能增收3000元，既 能挣钱，又能照顾家人，日子越过越有奔头。 眼下，在湖北省竹溪县山岗上的林下坡地，林农们正在采收天麻、种植猪苓、移栽青风藤等中药材。 竹溪现有森林面积430余万亩，山场资源丰富。近年来，竹溪县15个乡镇、10个农林场抢抓全县大力发展林下经济的机遇，各地因地制宜，科学规 划，依靠以奖代补政策扶持，组织动员广大专业合作社、公司、企业、个体户、家庭农场等，积极发展林下种植、养殖业以及相关产业。目前，全县林下 经济总面积达95万亩，省级林业重点龙头企业总数达14家，林业综合产值突破83亿元，带动了7.4万农户增收致富。 处于高海拔地区的向坝村，积极探索天麻与猪苓轮作模式，让深山的生态优势结出致富果实。 天麻收罢种猪苓，一根菌棒两茬金。在向坝村林下经济示范基地，100亩集体土地上种着天麻，待天麻采收后，同一地块 ...

内容概要：玄参是清热凉血类核心中药材，作为多种经典方剂和中成药的关键原料，其需求随中医药临 床应用推广、中医药产业政策扶持持续稳步增长，此外，随着国民健康意识的不断提升，对慢性病管 理、日常养生的重视度提升，玄参的清热凉血、滋阴降火等功效被广泛认知，逐渐被应用于保健品、功 能性食品、养生饮品等领域，带动玄参市场需求进一步扩大，据统计，2024年我国玄参需求量达415.91 吨，市场规模达2.49亿元。 相关上市企业：康美药业（600518）、国药股份（600511） 相关企业：国药集团冯了性（佛山）药材饮片有限公司、四川国强中药饮片有限公司、洪雅县瓦屋山药 业有限公司、亳州市京皖中药饮片厂、杭州胡庆余堂药业有限公司、九信中药集团有限公司、亳州市永 刚饮片厂有限公司、四川新荷花中药饮片股份有限公司、河北康益强药业有限公司 关键词：玄参市场政策、玄参产业链图谱、玄参供需现状、玄参市场规模、玄参竞争格局、玄参发展趋 势 一、概述 玄参别名黑参、元参，是玄参科玄参属多年生草本植物，高可达1.5米。根肥大，圆锥形或纺锤形，长 5-12厘米，直径1.3-3厘米，下部常分叉，表面灰黄色或灰褐色，断面乌黑色。茎直立，四棱形， ...

Group 1 - The traditional Chinese medicine (TCM) industry is a key and advantageous industry in Juancheng County, Shandong Province, with a focus on the cultivation, processing, and sales of medicinal herbs [3] - The Shunwangcheng TCM professional market is the only national-level TCM market in Shandong Province, facilitating a comprehensive industrial chain that integrates cultivation, production, sales, storage, logistics, and research [3] - In the first half of this year, the transaction volume of the Juancheng TCM market reached 6.05 billion yuan, with an increase of 18,000 mu in TCM planting area and the establishment of five high-standard planting bases [3] Group 2 - Shandong Shun Agricultural Development Co., Ltd. has leased 900 mu of land for TCM cultivation, focusing on varieties like Ophiopogon japonicus and Scutellaria baicalensis, which are well-suited for local soil and have good market prices [2] - The company ensures stable sales channels through long-term partnerships with TCM markets in Hebei and Anhui, resulting in an average annual income increase of over 20,000 yuan for local villagers [2] - The company also processes and exports TCM products to countries like Japan and South Korea, enhancing its market reach [2] Group 3 - Individual farmer Cha Shibang cultivates 43 mu of medicinal herbs, employing crop rotation methods to enhance soil fertility and reduce pest issues, achieving profits of 3,000 to 10,000 yuan per mu [1] - The scientific crop rotation model used by farmers significantly improves land productivity and sustainability [1] - The integration of TCM cultivation with traditional farming practices contributes to the overall economic development of the region [1]

Group 1: Financial Performance - The company repurchased 5.35 million restricted stock units using 18.76 million CNY of its own funds in 2024 [2] - The net profit for 2024 significantly declined due to three main factors: goodwill impairment, increased R&D expenses by 52.64%, and decreased profits in the healthcare sector due to policy reforms [2][3] - The company reported a goodwill increase of 121,391,986.07 CNY from acquiring 51% of Meishan Hospital, which negatively impacted the profit by 77,018,945.37 CNY due to retrospective adjustments [2][4] Group 2: Future Growth Strategies - The company plans to enhance profitability by focusing on three areas: accelerating new product R&D, increasing sales of existing high-margin products, and improving cost management [2] - The company has established a 355-acre traditional Chinese medicine demonstration base to promote cultivation and quality control [3] - The company is investing in R&D for various therapeutic areas, including anti-anemia, gynecology, nephrology, and medical devices, to improve innovation and market competitiveness [4] Group 3: Shareholder Engagement - As of April 1, 2025, the number of shareholders is 35,487 [3] - The company has distributed over 1.88 billion CNY in dividends since its listing, with annual dividends exceeding 50% of the net profit in the last three years [3] - The company plans to disclose its Q1 2025 report on April 28, 2025 [4]